The U.S. Food and Drug Administration is reportedly opening up a politically-charged investigation into the safety of the abortion pill mifepristone — a drug long considered to be the gold standard for early medical abortions.
The investigation, spurred by conversations with anti-abortion groups and an October deadline from a Louisiana judge, is expected to take around six months, Trump administration officials told The Wall Street Journal Thursday night.
